Professor Tim Illidge completed an undergraduate degree in Biochemistry (BSc) at London University before graduating with his medical degree (MB BS) from Guy’s Hospital Medical School, London. Prof Illidge has subsequently been awarded a PhD for his work in the area of lymphomas from the University of Southampton.
In 1998 he received a US Senior Fulbright Fellowship and a Winston Churchill Fellowship enabling him to work as part of the lymphoma team at Stanford University. He has also completed research fellowships as the Cancer Research UK Senior Clinical Research Fellow. Prof Illidge is a Member of the Royal College of Physicians and the American Society of Hematologists and is a Fellow of the Royal College of Radiologists and the Royal College of Pathologists.
Prof Illidge is an internationally renowned expert in antibodies and the treatment of lymphomas with radioimmunotherapy, on which he has published extensively. He currently serves on the National Cancer Research lymphoma group and runs a Cancer Research UK research group from the Paterson Institute and Christie Hospital, Manchester, where he is researching new antibody-based therapies for lymphoma.
He specialises in the management of non-Hodgkin and Hodgkin lymphomas both through the use of systemic immuno-chemotherapy and radiotherapy. He treats patients at the Christie Hospital in Manchester.
